Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1995-06-06
1997-11-11
Eisenschenk, Frank C.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
5303897, 5303913, 435328, 4353201, 435344, 424 91, 536 2353, A61K 39395, C07K 1628, C12N 512
Patent
active
056865830
ABSTRACT:
The invention relates to monoclonal antibodies and parts thereof which bind preferentially to active human platelets, to the nucleotide sequence and amino-acid sequence of the heavy and light chain of MAb BW 2128 and to an antigen associated with thrombospondin.
REFERENCES:
patent: 4610960 (1986-09-01), Mosher
D. Collen, The Lancet, 1993, 342:34.
Harlow et al., 1988, pp. 285-287.
Morrison et al., Hospital Practice, 1989, pp. 65-80.
A Thrombin-Sensitive Protein of Human Platelet Membranes, Baenziger et al. Proc. Nat. Acad. Sci., 68:240-243 (1971).
Immunohistochemical Localization of Membrane and .alpha.-Granule Proteins in Human Megakaryocytes: Application to Plastic-Embedded Bone Marrow Biopsy Specimens, Beckstead et al., Blood, 67(2):285-293 (1986).
Immunohistochemical Localization and Molecular Characteristics of Three Monoclonal Antibody-Defined Epitopes Detectable on Carcinoembryonic Antigen (CEA), Bosslet et al., Int. J. Cancer, 36:75-84 (1985).
Immunoenzymatic Labeling of Monoclonal Antibodies Using Immune Complexes of Alkaline Phosphatase and Monoclonal Anti-Alkaline Phosphatase (APAAP Complexes), Cordell et al., J. Histochem. (Cytochem., 32(2):219-229 (1984).
Effects of Anti-Thrombospondin Monoclonal Antibodies on The Agglutination of Erythrocytes and Fixed, Activated by Purified Thrombospondin, Dixit et al., Biochemistry, 24:4270-4275 (1985).
Isolation and Characterization of a Heparin-Binding Domain From The Amino Terminus of Platelet Thrombospondin, Dixit et al., J. Biol. Chem., 259(16):10100-10105 (1984).
Immunochemical Identification of a Thrombospondin-Like Structure In An Arterial Microfibrillar Extract, Fauvel-Lafeve et al., Thromb. Research, 50:305-316 (1988).
Isolation and Properties of a Thrombin-Sensitive Protein from Human Blood Platelets, Ganguly, J. Biol. Chem., 246(13):4268-4290 (1971).
Humanization of Monoclonal Antibodies, Gussow et al., Methods in Enzymology, 203:99-121 (1991).
Antigenic Sites in Carcinoembryonic Antigen, Hammarstrom et al., Cancer Research, 49:4852-4858 (1989).
Antibody-Targeted Thrombolytic Agents, Haber et al., Japanese Circulation Journal, 54:345-353 (1989).
Multimerin: A Series of Large Disulfide-Linked Multimeric Proteins Within Platelets, Hayward et al., Blood, 77 (12):2555-2560 (1991).
Evolution of Human Immunoglobulin k J Region Genes, Hieter et al., Journal of Biological Chemistry, 257(3):1516-1522 (1982).
Establishment of Mammalian Cell Lines Containing Multiple Nonsense Mutations and Functional Suppressor tRNA Genes, Hudziak et al., Cell, 31:137-146 (1982).
Cultured Human Fibroblasts Synthesize and Secrete Thrombospondin and Incorporate it into Extracellular Matrix, Jaffe et al., Proc. Natl. Acad. Sci. USA, 80:998-1002 (1983).
Glucocorticoids Regulate Expression of Dihydrofolate Reductase cDNA in Mouse Mammary Tumour Virus Chimaeric Plasmids, Lee et al., Nature, 294:228-232 (1981).
Use of Radiolabelled Monoclonal Anti-CEA Antibodies for the Detection of Human Carcinomas by External Photoscanning and Tomoscintigraphy, Mach et al., Immunology Today, 2:239-249 (1981).
Thrombospondin is Present in Articular Cartilage and is Synthesized by Articular Chondocytes, Miller et al., Biochem. Biophys. Res. Commun., 153(2):708-714 (1988).
Regulation of Thrombospondin Secretion by Cells in Culture, Mumby et al., J. Cell. Physiol., 120:280-288 (1984).
High Resolution Two-Dimensional Electrophoresis of Proteins, O'Farrell, J. Biol. Chem., 250(10):4007-4021 (1975).
Cloning Immunoglobulin Variable Domains for Expression By the Polymerase Chain Reaction, Orlandi et al., Proc. Natl. Acad. Sci. USA, 86:3833-3837 (1989).
A New Medium Improves Sampling for Determination of Platelet Factor 4 in Human Plasma, Osei-Bonsu et al., Wiener Klin. Wschr. 99:595-600 (1987).
Evaluation of the In Vitro and Ex Vivo Blood Compatibility of Primary Reference Materials, Pelzer et al., Journal of Biomedical Material Res. 20:1401-1409 (1986).
Thrombospondin Is An Osteoblast-Derived Component of Mineralized Extracellular Matrix, Robey et al., J. Cell Biol., 108:719-727 (1989).
A Novel Approach to Tc-99m-Labeled Monoclonal Antibodies, Schwarz et al., J. Nucl. Med., 28 (4):721 (1987).
Granular Pneumocytes in Primary Culture Secrete Several Major Components of the Extracellular Matrix, Sage et al., Biochemistry, 22:2148-2155 (1983).
DNA Sequencing With Chain-Terminating Inhibitors, Sanger et al., Proc. Natl. Acad. Sci. USA, 74(12):5463-5467 (1977).
Expression of Biologically Active Human Antithrombin III in Chinese Hamster Ovary Cells, Zettlmeissl et al., Bio/Technology, 5:720-725 (1987).
Design and Synthesis of a Mimetic From an Antibody Complementarity Determining Region, Saragovi et al., Science, 253:792-795 (1991).
Light Microscopic Immunolocation of Thrombospondin in Human Tissues, Wight et al., Journal of Histochem. and Cytochem., 33(4):295-302 (1985).
Electrophoretic Transfer of Proteins From Polyacrylamide Gels to Nitrocellulose Sheets: Procedure And Some Applications, Towbin et al., Proc. Natl. Acad. Sci. USA, 76(9):4350-4354 (1979).
Isolation of Overproducing Recombinant Mammalian Cell Lines By a Fast And Simple Selection Procedure, Wirth et al., Gene, 73:419-426 (1988).
Efficient Expression System for Human Antithrombin III in Baby Hamster Kidney Cells, Zettlmeissl et al., Behring Institute Mitteilungen 82:26-34 (1988).
K. Bosslet, et al., "Quantitative considerations supporting the irrelevance of circulating serum CEA for the immunoscintigraphic visualization of CEA expressing carcinomas," European Journal of Nuclear Medicine (1988) 14:523-528.
Gert Riethmuller, et al., "Randomized trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma," The Lancet, vol. 343 (May 14, 1994), pp. 1177-1183.
Maria I Colnaghi, et al., "Evolution of the therapeutic use of new monoclonal antibodies," Current Opinion in Oncology, (1993), 5:1035-1042.
Asch et al., "Cellular Attachment to Thrombospondin, Cooperative Interactions Between Receptor Systems," J. Biol. Chem., 266(3):1740-1745 (1991).
Winter et al., "Man-made Antibodies," Nature, 349:293-299 (1991).
Bosslet Klaus
Kehrel Beate
Seemann Gerhard
Behringwerke Aktiengesellschaft
Eisenschenk Frank C.
LandOfFree
Specific antibodies against activated platelets, the preparation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Specific antibodies against activated platelets, the preparation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Specific antibodies against activated platelets, the preparation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1230304